We are live on ! Find out more
RFM

Royal Fund Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 32.21%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+32.21%
3 Year Est. Return
+92.42%
5 Year Est. Return
+97.01%
10 Year Est. Return
AUM
$602M
AUM Growth
-$88.6M
Cap. Flow
+$19.1M
Cap. Flow %
3.17%
Top 10 Hldgs %
23.83%
Holding
232
New
28
Increased
95
Reduced
59
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 9.86%
2 Healthcare 7.03%
3 Consumer Discretionary 5.19%
4 Industrials 5.01%
5 Consumer Staples 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUM icon
26
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
$6.82M 1.13%
50,034
+846
+2% +$124K
RTX icon
27
RTX Corp
RTX
$290B
$6.43M 1.07%
66,949
+8,875
+15% +$853K
ABBV icon
28
AbbVie
ABBV
$443B
$6.31M 1.05%
41,206
+1,894
+5% +$289K
USB icon
29
US Bancorp
USB
$98.2B
$6.29M 1.04%
136,581
+5,454
+4% +$272K
QCOM icon
30
Qualcomm
QCOM
$155B
$6M 1%
46,943
-713
-1% -$96.8K
IYH icon
31
iShares US Healthcare ETF
IYH
$3.37B
$5.93M 0.99%
110,320
+8,315
+8% +$456K
NEM icon
32
Newmont
NEM
$98.7B
$5.75M 0.96%
96,321
-9,634
-9% -$682K
MRK icon
33
Merck
MRK
$322B
$5.68M 0.94%
62,270
+58
+0.1% +$5.14K
VONG icon
34
Vanguard Russell 1000 Growth ETF
VONG
$42.8B
$5.61M 0.93%
99,691
-3,086
-3% -$191K
BMY icon
35
Bristol-Myers Squibb
BMY
$133B
$5.53M 0.92%
71,877
+1,654
+2% +$126K
CVS icon
36
CVS Health
CVS
$133B
$5.51M 0.92%
59,526
+689
+1% +$67.2K
IBM icon
37
IBM
IBM
$211B
$5.41M 0.9%
38,283
+2,460
+7% +$332K
DIA icon
38
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$5.4M 0.9%
17,539
-14,312
-45% -$4.68M
IJJ icon
39
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$5.21M 0.87%
+55,191
New +$5.63M
IJS icon
40
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$5.18M 0.86%
+58,194
New +$5.58M
PSX icon
41
Phillips 66
PSX
$84.9B
$5.09M 0.85%
62,093
+1,055
+2% +$97.6K
IYR icon
42
iShares US Real Estate ETF
IYR
$4.66B
$5.06M 0.84%
55,056
-47,707
-46% -$4.76M
XHE icon
43
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
$5.04M 0.84%
59,385
-202
-0.3% -$19K
UNP icon
44
Union Pacific
UNP
$174B
$4.99M 0.83%
23,385
+2,351
+11% +$535K
TSLA icon
45
Tesla
TSLA
$1.23T
$4.97M 0.83%
22,152
+924
+4% +$252K
DGRO icon
46
iShares Core Dividend Growth ETF
DGRO
$42.7B
$4.94M 0.82%
103,712
+1,365
+1% +$68.8K
IYM icon
47
iShares US Basic Materials ETF
IYM
$1.12B
$4.9M 0.81%
+41,613
New +$5.75M
AMGN icon
48
Amgen
AMGN
$208B
$4.73M 0.79%
19,455
+650
+3% +$159K
DRI icon
49
Darden Restaurants
DRI
$23.3B
$4.67M 0.78%
41,251
+9,401
+30% +$1.17M
PG icon
50
Procter & Gamble
PG
$336B
$4.61M 0.77%
32,053
-4,381
-12% -$658K

Similar funds

Royal Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Royal Fund Management held 232 positions worth $602M, down 13% from $690M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Royal Fund Management deployed $19.1M of net new capital in Q2 2022, opening 28 new positions and adding to 95 existing holdings. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 96,607 shares worth $9.88M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares S&P 500 Growth ETF, an estimated $9.44M trimmed.

  • Royal Fund Management's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 96,607 shares worth $9.88M.
  • Royal Fund Management added most to iShares TIPS Bond ETF in Q2 2022, an estimated $3.13M increase.
  • Royal Fund Management's biggest Q2 2022 reduction was iShares S&P 500 Growth ETF, cutting an estimated $9.44M.
  • Royal Fund Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2022, selling an estimated $5.19M.
  • Royal Fund Management's ten largest holdings make up 24% of its $602M portfolio in Q2 2022.
  • Royal Fund Management opened 28 new positions and closed 34 in Q2 2022.
  • Royal Fund Management's portfolio value fell 13% quarter-over-quarter to $602M.

Based on Royal Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.